Thomas Fuchs, DSc, joined New York City-based Mount Sinai Health System as co-director of its digital health institute and dean of expert system and human health, according to an Oct. 7 news release..
Jackie Drees –
Thursday, October 8th, 2020
5 things to know:.
1. Dr. Fuchs concentrates on computational pathology, which is the use of AI to analyze tissue sample images to identify illness and anticipate outcomes..
2. In addition to his new roles as dean of AI and human health at Mount Sinai School of Medicine and co-director of the Hasso Plattner Institute for Digital Health, Dr. Fuchs will also act as a computational pathology and computer technology teacher at Mount Sinais medical school..
3. Through his new positions, Dr. Fuchs will focus on producing a brand-new system and code for artificial intelligence, improving the effectiveness of data in scientific settings and expanding using computational pathology in medical treatments..
4. In his previous digital health and computational pathology work, Dr. Fuchs developed new techniques for examining digital microscopy slides to better comprehend hereditary anomalies and their impact on modifications in tissue. He likewise produced systems to map the pathology, origins and progress of cancer..
5. Prior to joining Mount Sinai, Dr. Fuchs functioned as director of Memorial Sloan Kettering Cancer Centers digital and computational pathology center, and he likewise co-founded AI pathology company Paige.AI in 2017..
© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by click on this link.
In his previous digital health and computational pathology work, Dr. Fuchs developed brand-new methods for evaluating digital microscopy slides to better understand genetic anomalies and their impact on changes in tissue. © Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this material? View our policies by clicking here.
More posts on artificial intelligence: NYU researchers establish AI tool that forecasts COVID-19 client outcomes with 90% precisionAI tool gains FDA emergency situation approval to help deal with COVID-19 clients: 4 detailsPittsburgh Health Data Alliance, Amazon Web Services developing AI models to find breast cancer, anxiety more quickly.